Global Generic Drugs Market Report 2019, Competitive Landscape, Trends and Opportunities
The Generic Drugs market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Generic Drugs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Generic Drugs market.
Major players in the global Generic Drugs market include:
Aurobindo
Aspen Pharmacare
Novartis-Sandoz
Allergan
Sun Pharmaceutical
Mylan
Teva Pharma
Pfizer (Hospira)
Sanofi
Fresenius Kabi
On the basis of types, the Generic Drugs market is primarily split into:
Small Molecule Generics
Biosimilars
On the basis of applications, the market covers:
Anti-infectives
CNS
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Generic Drugs market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Generic Drugs market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Generic Drugs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Generic Drugs market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Generic Drugs, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Generic Drugs in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Generic Drugs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Generic Drugs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Generic Drugs market, including the global production and revenue forecast, regional forecast. It also foresees the Generic Drugs market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Generic Drugs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Generic Drugs market.
Major players in the global Generic Drugs market include:
Aurobindo
Aspen Pharmacare
Novartis-Sandoz
Allergan
Sun Pharmaceutical
Mylan
Teva Pharma
Pfizer (Hospira)
Sanofi
Fresenius Kabi
On the basis of types, the Generic Drugs market is primarily split into:
Small Molecule Generics
Biosimilars
On the basis of applications, the market covers:
Anti-infectives
CNS
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Generic Drugs market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Generic Drugs market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Generic Drugs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Generic Drugs market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Generic Drugs, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Generic Drugs in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Generic Drugs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Generic Drugs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Generic Drugs market, including the global production and revenue forecast, regional forecast. It also foresees the Generic Drugs market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 GENERIC DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Generic Drugs
1.2 Generic Drugs Segment by Type
1.2.1 Global Generic Drugs Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Small Molecule Generics
1.2.3 The Market Profile of Biosimilars
1.3 Global Generic Drugs Segment by Application
1.3.1 Generic Drugs Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Anti-infectives
1.3.3 The Market Profile of CNS
1.3.4 The Market Profile of Others
1.4 Global Generic Drugs Market by Region (2014-2026)
1.4.1 Global Generic Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Generic Drugs Market Status and Prospect (2014-2026)
1.4.3 Europe Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.1 Germany Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.2 UK Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.3 France Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.4 Italy Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.5 Spain Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.6 Russia Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.7 Poland Generic Drugs Market Status and Prospect (2014-2026)
1.4.4 China Generic Drugs Market Status and Prospect (2014-2026)
1.4.5 Japan Generic Drugs Market Status and Prospect (2014-2026)
1.4.6 India Generic Drugs Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Generic Drugs Market Status and Prospect (2014-2026)
1.4.8 Central and South America Generic Drugs Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Generic Drugs Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Generic Drugs Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Generic Drugs Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Generic Drugs Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Generic Drugs (2014-2026)
1.5.1 Global Generic Drugs Revenue Status and Outlook (2014-2026)
1.5.2 Global Generic Drugs Production Status and Outlook (2014-2026)
2 GLOBAL GENERIC DRUGS MARKET LANDSCAPE BY PLAYER
2.1 Global Generic Drugs Production and Share by Player (2014-2019)
2.2 Global Generic Drugs Revenue and Market Share by Player (2014-2019)
2.3 Global Generic Drugs Average Price by Player (2014-2019)
2.4 Generic Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Generic Drugs Market Competitive Situation and Trends
2.5.1 Generic Drugs Market Concentration Rate
2.5.2 Generic Drugs Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Aurobindo
3.1.1 Aurobindo Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Generic Drugs Product Profiles, Application and Specification
3.1.3 Aurobindo Generic Drugs Market Performance (2014-2019)
3.1.4 Aurobindo Business Overview
3.2 Aspen Pharmacare
3.2.1 Aspen Pharmacare Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Generic Drugs Product Profiles, Application and Specification
3.2.3 Aspen Pharmacare Generic Drugs Market Performance (2014-2019)
3.2.4 Aspen Pharmacare Business Overview
3.3 Novartis-Sandoz
3.3.1 Novartis-Sandoz Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Generic Drugs Product Profiles, Application and Specification
3.3.3 Novartis-Sandoz Generic Drugs Market Performance (2014-2019)
3.3.4 Novartis-Sandoz Business Overview
3.4 Allergan
3.4.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Generic Drugs Product Profiles, Application and Specification
3.4.3 Allergan Generic Drugs Market Performance (2014-2019)
3.4.4 Allergan Business Overview
3.5 Sun Pharmaceutical
3.5.1 Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Generic Drugs Product Profiles, Application and Specification
3.5.3 Sun Pharmaceutical Generic Drugs Market Performance (2014-2019)
3.5.4 Sun Pharmaceutical Business Overview
3.6 Mylan
3.6.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Generic Drugs Product Profiles, Application and Specification
3.6.3 Mylan Generic Drugs Market Performance (2014-2019)
3.6.4 Mylan Business Overview
3.7 Teva Pharma
3.7.1 Teva Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Generic Drugs Product Profiles, Application and Specification
3.7.3 Teva Pharma Generic Drugs Market Performance (2014-2019)
3.7.4 Teva Pharma Business Overview
3.8 Pfizer (Hospira)
3.8.1 Pfizer (Hospira) Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Generic Drugs Product Profiles, Application and Specification
3.8.3 Pfizer (Hospira) Generic Drugs Market Performance (2014-2019)
3.8.4 Pfizer (Hospira) Business Overview
3.9 Sanofi
3.9.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Generic Drugs Product Profiles, Application and Specification
3.9.3 Sanofi Generic Drugs Market Performance (2014-2019)
3.9.4 Sanofi Business Overview
3.10 Fresenius Kabi
3.10.1 Fresenius Kabi Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Generic Drugs Product Profiles, Application and Specification
3.10.3 Fresenius Kabi Generic Drugs Market Performance (2014-2019)
3.10.4 Fresenius Kabi Business Overview
4 GLOBAL GENERIC DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Generic Drugs Production and Market Share by Type (2014-2019)
4.2 Global Generic Drugs Revenue and Market Share by Type (2014-2019)
4.3 Global Generic Drugs Price by Type (2014-2019)
4.4 Global Generic Drugs Production Growth Rate by Type (2014-2019)
4.4.1 Global Generic Drugs Production Growth Rate of Small Molecule Generics (2014-2019)
4.4.2 Global Generic Drugs Production Growth Rate of Biosimilars (2014-2019)
5 GLOBAL GENERIC DRUGS MARKET ANALYSIS BY APPLICATION
5.1 Global Generic Drugs Consumption and Market Share by Application (2014-2019)
5.2 Global Generic Drugs Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Generic Drugs Consumption Growth Rate of Anti-infectives (2014-2019)
5.2.2 Global Generic Drugs Consumption Growth Rate of CNS (2014-2019)
5.2.3 Global Generic Drugs Consumption Growth Rate of Others (2014-2019)
6 GLOBAL GENERIC DRUGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Generic Drugs Consumption by Region (2014-2019)
6.2 United States Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.4 China Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.6 India Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Generic Drugs Production, Consumption, Export, Import (2014-2019)
7 GLOBAL GENERIC DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Generic Drugs Production and Market Share by Region (2014-2019)
7.2 Global Generic Drugs Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
8 GENERIC DRUGS MANUFACTURING ANALYSIS
8.1 Generic Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Generic Drugs
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Generic Drugs Industrial Chain Analysis
9.2 Raw Materials Sources of Generic Drugs Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Generic Drugs
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL GENERIC DRUGS MARKET FORECAST (2019-2026)
11.1 Global Generic Drugs Production, Revenue Forecast (2019-2026)
11.1.1 Global Generic Drugs Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Generic Drugs Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Generic Drugs Price and Trend Forecast (2019-2026)
11.2 Global Generic Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Generic Drugs Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Generic Drugs Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Generic Drugs
1.2 Generic Drugs Segment by Type
1.2.1 Global Generic Drugs Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Small Molecule Generics
1.2.3 The Market Profile of Biosimilars
1.3 Global Generic Drugs Segment by Application
1.3.1 Generic Drugs Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Anti-infectives
1.3.3 The Market Profile of CNS
1.3.4 The Market Profile of Others
1.4 Global Generic Drugs Market by Region (2014-2026)
1.4.1 Global Generic Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Generic Drugs Market Status and Prospect (2014-2026)
1.4.3 Europe Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.1 Germany Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.2 UK Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.3 France Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.4 Italy Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.5 Spain Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.6 Russia Generic Drugs Market Status and Prospect (2014-2026)
1.4.3.7 Poland Generic Drugs Market Status and Prospect (2014-2026)
1.4.4 China Generic Drugs Market Status and Prospect (2014-2026)
1.4.5 Japan Generic Drugs Market Status and Prospect (2014-2026)
1.4.6 India Generic Drugs Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Generic Drugs Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Generic Drugs Market Status and Prospect (2014-2026)
1.4.8 Central and South America Generic Drugs Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Generic Drugs Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Generic Drugs Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Generic Drugs Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Generic Drugs Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Generic Drugs Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Generic Drugs (2014-2026)
1.5.1 Global Generic Drugs Revenue Status and Outlook (2014-2026)
1.5.2 Global Generic Drugs Production Status and Outlook (2014-2026)
2 GLOBAL GENERIC DRUGS MARKET LANDSCAPE BY PLAYER
2.1 Global Generic Drugs Production and Share by Player (2014-2019)
2.2 Global Generic Drugs Revenue and Market Share by Player (2014-2019)
2.3 Global Generic Drugs Average Price by Player (2014-2019)
2.4 Generic Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Generic Drugs Market Competitive Situation and Trends
2.5.1 Generic Drugs Market Concentration Rate
2.5.2 Generic Drugs Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Aurobindo
3.1.1 Aurobindo Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Generic Drugs Product Profiles, Application and Specification
3.1.3 Aurobindo Generic Drugs Market Performance (2014-2019)
3.1.4 Aurobindo Business Overview
3.2 Aspen Pharmacare
3.2.1 Aspen Pharmacare Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Generic Drugs Product Profiles, Application and Specification
3.2.3 Aspen Pharmacare Generic Drugs Market Performance (2014-2019)
3.2.4 Aspen Pharmacare Business Overview
3.3 Novartis-Sandoz
3.3.1 Novartis-Sandoz Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Generic Drugs Product Profiles, Application and Specification
3.3.3 Novartis-Sandoz Generic Drugs Market Performance (2014-2019)
3.3.4 Novartis-Sandoz Business Overview
3.4 Allergan
3.4.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Generic Drugs Product Profiles, Application and Specification
3.4.3 Allergan Generic Drugs Market Performance (2014-2019)
3.4.4 Allergan Business Overview
3.5 Sun Pharmaceutical
3.5.1 Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Generic Drugs Product Profiles, Application and Specification
3.5.3 Sun Pharmaceutical Generic Drugs Market Performance (2014-2019)
3.5.4 Sun Pharmaceutical Business Overview
3.6 Mylan
3.6.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Generic Drugs Product Profiles, Application and Specification
3.6.3 Mylan Generic Drugs Market Performance (2014-2019)
3.6.4 Mylan Business Overview
3.7 Teva Pharma
3.7.1 Teva Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Generic Drugs Product Profiles, Application and Specification
3.7.3 Teva Pharma Generic Drugs Market Performance (2014-2019)
3.7.4 Teva Pharma Business Overview
3.8 Pfizer (Hospira)
3.8.1 Pfizer (Hospira) Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Generic Drugs Product Profiles, Application and Specification
3.8.3 Pfizer (Hospira) Generic Drugs Market Performance (2014-2019)
3.8.4 Pfizer (Hospira) Business Overview
3.9 Sanofi
3.9.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Generic Drugs Product Profiles, Application and Specification
3.9.3 Sanofi Generic Drugs Market Performance (2014-2019)
3.9.4 Sanofi Business Overview
3.10 Fresenius Kabi
3.10.1 Fresenius Kabi Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Generic Drugs Product Profiles, Application and Specification
3.10.3 Fresenius Kabi Generic Drugs Market Performance (2014-2019)
3.10.4 Fresenius Kabi Business Overview
4 GLOBAL GENERIC DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Generic Drugs Production and Market Share by Type (2014-2019)
4.2 Global Generic Drugs Revenue and Market Share by Type (2014-2019)
4.3 Global Generic Drugs Price by Type (2014-2019)
4.4 Global Generic Drugs Production Growth Rate by Type (2014-2019)
4.4.1 Global Generic Drugs Production Growth Rate of Small Molecule Generics (2014-2019)
4.4.2 Global Generic Drugs Production Growth Rate of Biosimilars (2014-2019)
5 GLOBAL GENERIC DRUGS MARKET ANALYSIS BY APPLICATION
5.1 Global Generic Drugs Consumption and Market Share by Application (2014-2019)
5.2 Global Generic Drugs Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Generic Drugs Consumption Growth Rate of Anti-infectives (2014-2019)
5.2.2 Global Generic Drugs Consumption Growth Rate of CNS (2014-2019)
5.2.3 Global Generic Drugs Consumption Growth Rate of Others (2014-2019)
6 GLOBAL GENERIC DRUGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Generic Drugs Consumption by Region (2014-2019)
6.2 United States Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.4 China Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.6 India Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Generic Drugs Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Generic Drugs Production, Consumption, Export, Import (2014-2019)
7 GLOBAL GENERIC DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Generic Drugs Production and Market Share by Region (2014-2019)
7.2 Global Generic Drugs Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Generic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
8 GENERIC DRUGS MANUFACTURING ANALYSIS
8.1 Generic Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Generic Drugs
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Generic Drugs Industrial Chain Analysis
9.2 Raw Materials Sources of Generic Drugs Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Generic Drugs
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL GENERIC DRUGS MARKET FORECAST (2019-2026)
11.1 Global Generic Drugs Production, Revenue Forecast (2019-2026)
11.1.1 Global Generic Drugs Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Generic Drugs Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Generic Drugs Price and Trend Forecast (2019-2026)
11.2 Global Generic Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Generic Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Generic Drugs Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Generic Drugs Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
